VIDEO: Faricimab demonstrates reduction in pigment epithelial detachment

In this video, Esther M. Bowie, MD, discusses a post hoc analysis comparing faricimab and aflibercept for the reduction of pigment epithelial detachment in patients with wet age-related macular degeneration.
The data from the TENAYA and LUCERNE trials were presented at the American Academy of Ophthalmology meeting.
“Faricimab seems to be good at decreasing pigment epithelial detachment, especially the ones with serous PED,” Bowie, professor of ophthalmology at Penn State Health Milton S. Hershey Medical Center, said.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart